Scientist I (NGS/MRD)

Location: Onsite in South San Francisco, California, United States

Salary: $130,000–$140,000 USD per year

Company

hirify.global is a diagnostics company developing genomic and clinical-data-driven cancer tests supported by bioinformatics, AI, and evidence generation.

What you will do

• Support the development, optimization, verification, and transfer of NGS-based MRD assays from feasibility through clinical laboratory implementation.
• Execute and analyze feasibility, characterization, optimization, and pre-validation studies.
• Prepare and characterize clinical and contrived samples for assay development and validation.
• Design experiments, interpret results, troubleshoot workflows, and implement technical improvements.
• Develop and optimize automated high-throughput laboratory workflows.
• Collaborate with Bioinformatics, Data Science, Operations, Clinical Laboratory, Automation, Quality, Regulatory, and Software/LIMS teams.

Requirements

• Ph.D. in Molecular Biology, Genetics, Biochemistry, Cancer Biology, or a related field.
• At least 3 years of relevant industry or postdoctoral experience in molecular diagnostics, biotechnology, genomics, or a related field.
• Hands-on experience with NGS workflows, library preparation, DNA- and/or RNA-based assays, and NGS quality control methods.
• Experience with experimental design, laboratory execution, data analysis, interpretation, troubleshooting, and assay optimization.
• Familiarity with statistical analysis and data visualization tools such as JMP, R, or Python.
• Must work onsite in South San Francisco, California, United States.

Nice to have

• Experience with blood, plasma, tissue, or FFPE clinical samples.
• Exposure to CAP/CLIA, NYSDOH, design control, or other regulated product development environments.
• Experience with oncology, liquid biopsy, ctDNA, or MRD technologies.

Culture & Benefits

• Purpose-driven work focused on improving cancer patient outcomes.
• Collaborative, multidisciplinary product development environment.
• Competitive compensation, discretionary bonus or incentive eligibility, and restricted stock units.
• Inclusive workplace with opportunities for professional growth.
• Employment in a company recognized as a 2024 Certified Great Place to Work in the United States and Israel.